When was CathVision founded?

CathVision was founded in 2013 and raised its 1st funding round 1 year after it was founded.

Where is CathVision located?

CathVision is headquartered in Copenhagen, Denmark. It is registered at Ole Maaløes Vej 3, 2200 København, Denmark.

Who is the current CEO of CathVision?

Mads Emil Matthiesen of CathVision.

Which legal entities is CathVision associated with?

CathVision is associated with Cathvision Aps.

How many employees does CathVision have?

As of Jul 31, 2026, the latest employee count at CathVision is 40.

Is CathVision a funded company?

CathVision is a funded company, having raised a total of $36.1M across 11 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Mar 24, 2014.

How much is CathVision worth?

The latest valuation of CathVision is $***** as of May 31, 2022. This marks a decline of 6% from its peak valuation of $30.1M in Mar, 2014. This marks a decline of 6% from its peak valuation of $30.1M in Mar, 2014.

When was the latest funding round of CathVision?

CathVision's latest funding was a $***** Series B round on Jul 18, 2023, with participation from 0 investor. Its primary sector is Healthcare IT. In Denmark, the Healthcare IT sector has seen $27.5M in funding in 2026 to date.

Where does CathVision rank among its competitors?

CathVision ranks 5th amongst 93 active competitors, of which 28 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was DASI Simulations, which secured $1.05M in Apr, 2026.

Who are the top competitors of CathVision?

CathVision's top competitors include AtaCor Medical, EBR Systems and AtriCure. Among them, DASI Simulations secured the most recent funding round in April, 2026.

CathVision - 2026 Company Profile, Team, Funding, Competitors & Financials

Company Details

Provider and developer of an AI-based cardiac ablation therapy software and device. It offers product CathVision Cube which has the ability to visualizes electrophysiology signals to support delivering accurate therapy. CathVision Cube is a product that comprises low-noise ablation therapy with signal quality to stream, analyze and store EP signals. The interface provides a real-time streaming review window for analysis using AI algorithms for clinical decision support. The software integrated into the device helps in analyzing and storage of EP signals.

Website: cathvision.com
Social
Email ID: *****@cathvision.com
Phone Number: +45 **********
Registered Address: Ole Maaløes Vej 3, 2200 København, Denmark

Key Metrics

Founded Year

2013

Location

Copenhagen, Denmark

Stage

Series B

Total Funding

$36.1M in 11 rounds

Latest Funding Round

Series B, Jul 18, 2023, $*****

Post Money Valuation

$***** as on May 31, 2022

Investors

Vaekstfonden & 7 more

Ranked

5^th among 93 active competitors

Employee Count

40 as on Jul 31, 2026

Similar Companies

AtaCor Medical & 116 more

View CathVision's full profile

CathVision is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Cathvision Aps CIN: 35205500 , Denmark, Active	Mar 24, 2013	-	21 (As on Nov 30, 2024)

CathVision has raised a total funding of $36.1M over 11 rounds. Its first funding round was on Mar 24, 2014. CathVision has 8 institutional investors.

Here is the list of recent funding rounds of CathVision:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jul 18, 2023	5709678	Series B	1897929	8184029	9347775	2211538
May 31, 2022	2067257	Series B	2356518	8937553	9554487	9119637
Jul 31, 2021	1149436	Grant (prize money)	2056055	1661101	2781907	EIC Fund

Access funding benchmarks and valuations. Sign up today!

View details of CathVision's funding rounds and investors

The founders of CathVision are Rune Orndrup and Mads Emil Matthiesen.

Here are the details of CathVision's key team members:

Rune Orndrup: Co-Founder of CathVision.
Mads Emil Matthiesen: Co-Founder & CEO of CathVision.
Contact Info: 1 email address

CathVision's Board of Directors

CathVision's board has 5 active members. Thor Jespersen, Tonni Bülow-Nielsen, Søren Thestrup Nielsen and Magnus Holm are part of team and Denis Gestin is independent board member.

Here is the list of CathVision's board of directors:

Name	Type	Representing	Status	Duration
uakbtzi	Team	-	Current	8y 8m
hrshqfj	Team	-	Current	6y 7m
ffxtsih	Team	-	Current	7y 6m
vbpwift	Team	-	Past	6y 8m
Denis Gestin	Independent board member	-	Current	7y 3m

View details of CathVision's Founder profiles and Board Members

CathVision's employee count trend

CathVision has 40 employees as of Jul 26. Here is CathVision's employee count trend over the years:

Uncover CathVision's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of CathVision include AtaCor Medical, EBR Systems and AtriCure. Here is the list of Top 10 competitors of CathVision, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	AtaCor Medical 2014, San Clemente (United States), Series D	Transforming cardiac rhythm management with innovative extravascular pacing and defibrillation solutions	$137M	aMoon, Broadview Ventures & 7 others	64/100
2nd	EBR Systems 2003, Sunnyvale (United States), Public	Revolutionizing cardiac rhythm management with leadless pacing technology for heart failure	$180M	Brandon Capital, M.H. Carnegie & Co & 12 others	60/100
3rd	AtriCure 2000, Mason (United States), Public	Medical device company focused on atrial fibrillation and pain management	-	Stage Capital, Camden Partners & 2 others	59/100
4th	CardioFocus 1990, Marlborough (United States), Series E	Endoscopically guided catheter for ablation	$261M	H.I.G. Capital, KBL & 22 others	58/100
5th	CathVision 2013, Copenhagen (Denmark), Series B	Provider and developer of an AI-based cardiac ablation therapy software and device	$36.1M	Nordic Secondary Fund, EIC Fund & 6 others	57/100
6th	DASI Simulations 2019, Dublin (United States), Seed	AI-based pre-procedural planning for structural heart surgery	$7M	Rev1 Ventures, HHS	55/100
7th	Kestra Medical Technologies 2014, Kirkland (United States), Public	Device to protect and support patients at risk of cardiovascular disorders	$196M	Bain Capital Life Sciences, Longitude Capital ... & 9 others	54/100
8th	YorLabs 2015, Beaverton (United States), Series A	Developer of an intracardiac image-guided therapy platform	$20.3M	TiE, Vectr Ventures & 1 others	54/100
9th	TyRx 1998, Monmouth Junction (United States), Acquired	Antibacterial envelopes for cardiac implants	$70.8M	MemorialCare Innovation Fund, HLM Venture Partners ... & 6 others	47/100
10th	Cameron Health 2001, San Clemente (United States), Acqui-Hired	Subcutaneous Implantable Defibrillator	$158M	Alloy Ventures, Western Technology Investment ... & 14 others	45/100